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Background: Drug-eluting stents (DES) improved prognosis after percutaneous coronary intervention. This study sought to compare long-term 
clinical outcomes of 1st generation DES, Sirolimus-Eluting Stent (SES) versus Paclitaxel-Eluting Stent (PES) during 7 years.
methods: Between Nov. 1998 and Feb 2012, total 3292 patients received intracoronary SES (2282) and PES (1010). Primary endpoint was the 
composite of cardiovascular deaths, myocardial infarction (MI), stent thrombosis (ST), and target lesion revascularization (TLR) during 7 years.
results: During the observation of 13,029.3 person-years (median 4.1 years), there were 65 deaths (2.8%), 38 MI (1.7%), 22 ST (0.9%), and 247 
TLR (12.2%). Although patients with SES developed fewer clinical events than those with PES during the first 3 years (HR 0.57, 95% CI 0.44~0.75, 
p<0.001), cumulative incidences became similar at 7 years between the groups (SES 15.0% vs. PES 14.5%, p=0.07) because of the higher event 
rate in patients with SES after 3 years (HR 1.92, 95% CI 1.18~3.12, p=0.009). (Figure 1~2) .This ‘late catch-up phenomenon’ was mainly driven by 
TLR, while incidences of cardiovascular deaths, MI and ST were similar throughout 7 years. (Figure 3)
conclusions: Comparing clinical events of SES and PES during 7 years, the ‘late catch-up phenomenon’ was observed because of fewer TLR in 
patients with SES until 3 years and more TLR after that. 
